Cite
MLA Citation
M Früh and S Peters. “EGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in non-small-cell lung cancer.” Annals of oncology, vol. 30, 2019, pp. 1190–1192. http://access.bl.uk/ark:/81055/vdc_100092360414.0x00002e